1 - 63 of 63
Title Published in Access level OA Policy Year Views Downloads
Prioritising at-risk adults in vaccine coadministration trialsThe Lancet. Infectious diseases
2025 14 0
Rituximab‐to‐vaccine interval on SARS‐CoV‐2 immunogenicity in children : The potential role of prior natural infectionPediatric allergy and immunology
2024 127 265
B and T cell responses to the 3rd and 4th dose of the BNT162b2 vaccine in dialysis patientsHuman vaccines & immunotherapeutics
2024 8 11
Characterisation of clinical response and transcriptional profiling of proliferating CD8 T cells in the blood of cancer patients after PD-1 monotherapy or combination therapyBMJ oncology
2024 6 12
Mise à jour des vaccins chez les personnes âgéesRevue médicale suisse
2024 65 0
Influence of timing of maternal pertussis immunization on the avidity of transferred antibodies in term and preterm neonatesClinical infectious diseases
2023 88 113
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19Frontiers in immunology
2023 202 50
High-throughput spatiotemporal monitoring of single-cell secretions via plasmonic microwell arraysNature biomedical engineering
2023 110 137
COVID-19 Vaccine Development - where do we stand?
2022 292 16
Omicron-specific cytotoxic t-cell responses after a third dose of mrna covid-19 vaccine among patients with multiple sclerosis treated with ocrelizumabJAMA neurology
2022 244 163
Adjuvanted recombinant zoster vaccine in solid organ transplant and hematopoietic stem-cell transplant recipientsCurrent opinion in infectious diseases
2022 73 390
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 yearsScientific reports
2022 114 20
Gynécologie-obstétrique - Grossesse et Covid-19 : recommandations médicamenteuses et vaccinales en 2021Revue médicale suisse
2022 83 57
A comparison of Sars-Cov-2 vaccine platforms : the CoviCompare projectNature medicine
2022 67 100
Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence90th EAS (European Atherosclerosis Society) Congress
2022 88 0
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not BetaNature
2022 1,452 214
Robust T-Cell Responses in Anti-CD20 Treated Patients Following COVID-19 Vaccination: A Prospective Cohort StudyClinical infectious diseases
2022 232 59
Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistenceEuropean journal of clinical investigation
2022 445 147
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCsNature communications
2022 285 189
T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipientsAnnals of oncology
2022 260 111
Contrasting behavior between the three human monocyte subsets in dengue pathophysiologyiScience
2022 71 35
Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive AnalysisFrontiers in immunology
2022 199 157
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation : An updated EASL position paperJournal of hepatology
2022 64 232
Is there a role for childhood vaccination against COVID-19?Pediatric allergy and immunology
2021 279 1
Maladies infectieusesRevue médicale suisse
2021 388 106
SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1EAS Congress 2021
2021 382 38
Defining HPV-specific B cell responses in patients with head and neck cancerNature
2021 121 0
The Potential Role of Nonhuman Primate Models to Better Comprehend Early Life Immunity and Maternal Antibody TransferVaccines
2021 114 151
Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunityCell reports
2021 438 284
Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infectionClinical Microbiology and Infection
2021 524 325
Vaccination against Cancer or Infectious Agents during Checkpoint Inhibitor TherapyVaccines
2021 76 150
Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of SymptomsJournal of clinical immunology
2021 314 175
Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipientsBone marrow transplantation
2021 336 2
Influenza Immunization in the Context of Preexisting ImmunityCold Spring Harbor perspectives in medicine
2021 56 25
Coronavirus disease 2019 vaccination in transplant recipientsCurrent opinion in infectious diseases
2021 110 0
Immunological assessment of pediatric multisystem inflammatory syndrome related to COVID-19Journal of the Pediatric Infectious Diseases Society
2021 332 124
Paradoxes and Uncertainties of Immunomodulatory Treatments in the Fight Against Coronavirus Disease 2019Clinical infectious diseases
2021 216 93
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal studyClinical Microbiology and Infection
2021 407 221
SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1European Journal of Clinical Investigation
2021 419 257
Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivityClinical microbiology and infection
2021 697 0
Faudra-t-il vacciner les enfants contre le Covid-19 ?Revue médicale suisse
2021 79 67
EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipientsJournal of hepatology
2021 95 182
Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancerNature
2021 139 0
Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipientsJournal of hepatology
2021 94 103
Multi-stage group testing improves efficiency of large-scale COVID-19 screeningJournal of Clinical Virology
2020 315 0
Persistence of varicella-zoster virus-specific plasma cells in adult human bone marrow following childhood vaccinationJournal of Virology
2020 438 0
Challenges and issues of SARS-CoV-2 pool testingThe Lancet Infectious Diseases
2020 315 4
Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case seriesmSphere
2020 520 208
Maternal antibodies inhibit neonatal and infant responses to vaccination by shaping the early-life B cell repertoire within germinal centersCell Reports
2019 323 275
Does Maternal Tdap Vaccination During Pregnancy Increase the Risk of Developing Chorioamnionitis? - A Monocentric, Retrospective, Observational Study
2019 103 4
Characterization of virus-specific immune response during varicella zoster virus encephalitis in a young adultClinical Infectious Diseases
2019 315 0
Understanding the immunology of the Zostavax shingles vaccineCurrent Opinion in Immunology
2019 290 0
Overcoming the neonatal limitations of inducing germinal centers through liposome-based adjuvants including c-type lectin agonists trehalose dibehenate or curdlanFrontiers in Immunology
2018 498 514
Review of maternal immunisation during pregnancy: focus on pertussis and influenzaSwiss Medical Weekly
2017 351 217
Pertussis Antibody Transfer to Preterm Neonates After Second- Versus Third-Trimester Maternal ImmunizationClinical Infectious Diseases
2017 622 284
Antenatal vaccination to decrease pertussis in infants: safety, effectiveness, timing, and implementationThe Journal of Maternal - Fetal & Neonatal Medicine
2017 462 0
Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussisClinical infectious diseases
2016 749 5
Recommandations de vaccination chez la femme enceinte : une piqûre de rappelRevue médicale suisse
2016 413 2
Reply to Abu Raya et alClinical infectious diseases
2016 435 3
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early LifeThe Journal of immunology
2015 678 2
Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: Preclinical proof of conceptVaccine
2015 617 207
The Seatbelt Syndrome-Do We Have a Chance?: A Report of 3 Cases With Review of LiteraturePediatric emergency care
2015 567 2
Cholestasis as the leading sign of a transmesenteric hernia in a split-liver transplanted child - a case report and review of literaturePediatric transplantation
2012 655 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack